Trial · NCT03711318
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
NCT03711318, Phase 3, Terminated, New York State Psychiatric Institute; results first posted 2022-12-22
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals. Trials, record NCT03711318. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03711318
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
- NCT number
- NCT03711318
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 8 participants, actual
- Lead sponsor
- New York State Psychiatric Institute
- Conditions
- Heroin Dependence
- Interventions
- Buprenorphine/naloxone
- First posted
- 2018-10-18
- Last updated
- 2022-12-22
- Results first posted
- 2022-12-22
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Heroin-dependent Patients Successfully Inducted Onto Vivitrol | 12 weeks | Number of patients who received the first Vivitrol injection among those who initiated the induction |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Proportion of Heroin-dependent Patients Successfully Inducted Onto Vivitrol | 12 weeks | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Heroin-dependent Patients Successfully Inducted Onto Vivitrol | Short-term Treatment With Buprenorphine | 3 | Participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Short-term Treatment With Buprenorphine | 8 | |
| Overall Study | COMPLETED | Short-term Treatment With Buprenorphine | 1 | |
| Overall Study | NOT COMPLETED | Short-term Treatment With Buprenorphine | 7 |
Source ClinicalTrials.gov
Adverse events1
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | depressive symptoms | Psychiatric disorders | Short-term Treatment With Buprenorphine | 1 | 8 | 1 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Short-term Treatment With Buprenorphine | 0 | 8 |
| Total, other adverse events | Short-term Treatment With Buprenorphine | 1 | 8 |
| Total, serious adverse events | Short-term Treatment With Buprenorphine | 0 | 8 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03711318
GET https://conductscience.org/api/trials/v1/NCT03711318/registered